CHU de Liège — Liège

Public research footprint of CHU de Liège, compiled from the ClinicalTrials.gov public registry.

219

Registered studies

Active

Recruiting now

105

Completed

Stopped or withdrawn

Most-studied conditions

Non-Small Cell Lung Cancer · PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or… · Interstitial Lung Disease · Progressive Pulmonary Fibrosis

Recently updated registry entries

NCT06052332 — Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy… (Recruiting)
NCT06571149 — Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and… (Recruiting)
NCT07332091 — Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU de Liège?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.